Urine exosomes from 284 patients who underwent testing to determine prostate cancer were collected and quantified by ELISA for prostate-specific membrane antigen (PSMA), showing that PSMA was upregulated in PCa patients compared to benign patients, with an AUC of 0.876 [71]. Here, FOLH1 is linked to prostate carcinoma.